These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12447162)

  • 1. The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
    Gattis WA; O'Connor CM; Gheorghiade M
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S48-54. PubMed ID: 12447162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure.
    Gattis WA; O'Connor CM
    Am J Cardiol; 2004 May; 93(9A):74B-6B. PubMed ID: 15144943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
    Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
    Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB
    Am J Cardiol; 2008 Dec; 102(11):1524-9. PubMed ID: 19026308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.
    Gheorghiade M; Gattis WA; Lukas MA; O'Connor CM;
    Am Heart J; 2003 Feb; 145(2 Suppl):S60-1. PubMed ID: 12594455
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes.
    Fonarow GC
    Am J Cardiol; 2004 May; 93(9A):77B-81B. PubMed ID: 15144944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study.
    Krantz MJ; Havranek EP; Haynes DK; Smith I; Bucher-Bartelson B; Long CS
    J Card Fail; 2008 May; 14(4):303-9. PubMed ID: 18474343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
    Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
    Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
    Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
    Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of clinical outcomes in patients given carvedilol for heart failure.
    Greenberg B; Lottes SR; Nelson JJ; Lukas MA; Fowler MB; Massie BM; Abraham WT; Gilbert EM; Franciosa JA;
    Am J Cardiol; 2006 Dec; 98(11):1480-4. PubMed ID: 17126654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.